132 related articles for article (PubMed ID: 37225494)
41. Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.
Shi HJ; Yang J; Eom JS; Ko JH; Peck KR; Kim UJ; Jung SI; Kim S; Seok H; Hyun M; Kim HA; Kim B; Joo EJ; Cheong HS; Jun CH; Wi YM; Kim J; Kym S; Lim S; Park Y
J Korean Med Sci; 2023 Jul; 38(28):e217. PubMed ID: 37463688
[TBL] [Abstract][Full Text] [Related]
42. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
[TBL] [Abstract][Full Text] [Related]
43. Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey.
Mediavilla JR; Lozy T; Lee A; Kim J; Kan VW; Titova E; Amin A; Zody MC; Corvelo A; Oschwald DM; Baldwin A; Fennessey S; Zuckerman JM; Kirn T; Chen L; Zhao Y; Chow KF; Maniatis T; Perlin DS; Kreiswirth BN
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632041
[TBL] [Abstract][Full Text] [Related]
44. Air dispersal of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Implications for hospital infection control during the fifth wave of coronavirus disease 2019 (COVID-19) due to the SARS-CoV-2 omicron variant in Hong Kong.
Wong SC; Chan VW; Yuen LL; AuYeung CH; Leung JO; Li CK; Kwok MO; So SY; Chen JH; Tam AR; Hung IF; To KK; Lo JY; Yuen KY; Cheng VC
Infect Control Hosp Epidemiol; 2023 Aug; 44(8):1321-1324. PubMed ID: 36278515
[TBL] [Abstract][Full Text] [Related]
45. Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants.
Esper FP; Adhikari TM; Tu ZJ; Cheng YW; El-Haddad K; Farkas DH; Bosler D; Rhoads D; Procop GW; Ko JS; Jehi L; Li J; Rubin BP
J Infect Dis; 2023 Feb; 227(3):344-352. PubMed ID: 36214810
[TBL] [Abstract][Full Text] [Related]
46. Sustained Low Incidence of Severe and Fatal COVID-19 Following Widespread Infection Induced Immunity after the Omicron (BA.1) Dominant in Gauteng, South Africa: An Observational Study.
Madhi SA; Kwatra G; Myers JE; Jassat W; Dhar N; Mukendi CK; Blumberg L; Welch R; Izu A; Mutevedzi PC
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992306
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants.
Trobajo-Sanmartín C; Miqueleiz A; Guevara M; Fernández-Huerta M; Burgui C; Casado I; Baigorria F; Navascués A; Ezpeleta C; Castilla J
J Infect Dis; 2023 Feb; 227(3):332-338. PubMed ID: 36179126
[TBL] [Abstract][Full Text] [Related]
48. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
49. Differences in Clinical Presentations of Omicron Infections with the Lineages BA.2 and BA.5 in Mecklenburg-Western Pomerania, Germany, between April and July 2022.
Goller KV; Moritz J; Ziemann J; Kohler C; Becker K; Hübner NO; The CoMV-Gen Study Group
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146837
[TBL] [Abstract][Full Text] [Related]
50. Increased Secondary Attack Rates among the Household Contacts of Patients with the Omicron Variant of the Coronavirus Disease 2019 in Japan.
Ogata T; Tanaka H; Tanaka E; Osaki N; Noguchi E; Osaki Y; Tono A; Wada K
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805724
[TBL] [Abstract][Full Text] [Related]
51. [Analyze the clinical characteristics of mild and severe SARS-CoV-2 infected patients based on the local Omicron variant epidemic].
Yan Y; Lyu C; Davgadorj C; Wang X; Sha M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jan; 35(1):32-36. PubMed ID: 36880235
[TBL] [Abstract][Full Text] [Related]
52. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
[TBL] [Abstract][Full Text] [Related]
53. Clinical characteristics of pediatric cases infected with the SARS-CoV-2 Omicron variant in a tertiary children's medical center in Shanghai, China.
Shen N; Wu YF; Chen YW; Fang XY; Zhou M; Wang WY; Tang MY; Pan QH; Ma J; Zhang H; Cao Q
World J Pediatr; 2023 Jan; 19(1):87-95. PubMed ID: 36251118
[TBL] [Abstract][Full Text] [Related]
54. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
[TBL] [Abstract][Full Text] [Related]
55. [Sixth wave of COVID-19 pandemic: Epidemiological survey in children].
Morimoto M; Tanaka M; Hori S; Shikata S
Nihon Koshu Eisei Zasshi; 2023 Nov; 70(11):749-758. PubMed ID: 37394495
[TBL] [Abstract][Full Text] [Related]
56. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
[TBL] [Abstract][Full Text] [Related]
57. Paediatric admissions with SARS-CoV-2 during the Delta and Omicron waves: an Australian single-centre retrospective study.
Cheng DR; Schrader S; McMinn A; Crawford NW; Tosif S; Mcnab S; Steer AC
BMJ Paediatr Open; 2023 Mar; 7(1):. PubMed ID: 36882231
[TBL] [Abstract][Full Text] [Related]
58. Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods.
Shoji K; Tsuzuki S; Akiyama T; Matsunaga N; Asai Y; Suzuki S; Iwamoto N; Funaki T; Yamada M; Ozawa N; Yamaguchi K; Miyairi I; Ohmagari N
J Infect Chemother; 2023 Jan; 29(1):33-38. PubMed ID: 36103949
[TBL] [Abstract][Full Text] [Related]
59. Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa.
Sun K; Tempia S; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; Carrim M; Martinson NA; Kahn K; Lebina L; du Toit JD; Mkhencele T; Viboud C; Cohen C;
Nat Commun; 2023 Jan; 14(1):246. PubMed ID: 36646700
[TBL] [Abstract][Full Text] [Related]
60. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
